AstraZeneca sells assets and signs gene therapy agreement with Pfizer

August 1, 2023

BMS Gains First FDA Approval For Drug That Treats Psoriasis

September 15, 2022

MorphoSys hands over preclinical cancer program to Novartis for a $23M payout

December 13, 2022

Must Read

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

July 22, 2026

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

July 22, 2026

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

July 20, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Sac-TMT and Keytruda Improve Progression-Free Survival in PD-L1-Negative NSCLC

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

The Return of M&A as a Growth Strategy in Biopharma

Top 10 Reasons Pharma Companies Are Building Internal AI Governance Teams

Why Traditional Pharma Marketing Models Are Being Rewritten

Tag: FDA Approval

FDA Expands Casgevy Approval to Children Aged 2 With Sickle Cell Disease and Beta Thalassemia

Editor Picks

AstraZeneca sells assets and signs gene therapy agreement with Pfizer

BMS Gains First FDA Approval For Drug That Treats Psoriasis

MorphoSys hands over preclinical cancer program to Novartis for a $23M payout

Must Read

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

Hot Topics

About Us

Follow Us